Juan José Rodríguez-Sevilla

19PUBLICATIONS
167CO-AUTHORS
Predictive and prognostic markersHaematological tumoursCancer geneticsGene and molecular therapyMedical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 10, 2026
Germline landscape stratification defines distinct molecular and prognostic groups in therapy related myeloid neoplasms.

|Jan 26, 2026
Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia.

Guillermo Montalban-Bravo, Chong Wu, Juan Jose Rodriguez-Sevilla

|Sep 03, 2025
Identification of 4 autophagy-related genetic variants as risk factors for chronic lymphocytic leukemia.

Antonio José Cabrera-Serrano, José Manuel Sánchez-Maldonado, Juan José Rodríguez-Sevilla

|Sep 11, 2024
BATF is a major driver of NK cell epigenetic reprogramming and dysfunction in AML.

Bijender Kumar, Anand Singh, Rafet Basar

|May 07, 2024
Advances in the management of higher-risk myelodysplastic syndromes: future prospects.

Georgina Gener-Ricos, Juan Jose Rodriguez-Sevilla, Samuel Urrutia

|Feb 01, 2024
Cytogenetic and Molecular Associations with Outcomes in Higher-Risk Myelodysplastic Syndromes Treated with Hypomethylating Agents plus Venetoclax.

Alexandre Bazinet, Sai Prasad Desikan, Ziyi Li

Pageof 4

Frequent Collaborators

6 joint publications

Xavier Calvo

5 joint publications

Juan Sainz

5 joint publications

Leonor Arenillas

4 joint publications

Marta Salido